Update on cardiac sarcoidosis.

Cardiac magnetic resonance imaging Cardiac sarcoidosis Sarcoidosis Ventricular tachycardia

Journal

Trends in cardiovascular medicine
ISSN: 1873-2615
Titre abrégé: Trends Cardiovasc Med
Pays: United States
ID NLM: 9108337

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 16 12 2021
revised: 20 04 2022
accepted: 27 04 2022
medline: 23 10 2023
pubmed: 4 5 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Cardiac sarcoidosis is an inflammatory myocardial disease of unknown etiology. It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis is often under-diagnosed or recognized partly due to the heterogeneous clinical presentation of the disease. The three most frequent clinical manifestations of cardiac sarcoidosis are atrioventricular block, ventricular arrhythmias, and heart failure. A definitive diagnosis of cardiac sarcoidosis can be made with histology findings from an endomyocardial biopsy. However, the diagnosis in the majority of cases is based on findings from the clinical presentation and advanced imaging due to the low sensitivity of endomyocardial biopsy. The Heart Rhythm Society (HRS) 2014 expert consensus statement and the Japanese Ministry of Health and Welfare criteria are the two most commonly used diagnostic criteria sets. This review article summarizes the available evidence on cardiac sarcoidosis, focusing on the diagnostic criteria and stepwise approach to its management.

Identifiants

pubmed: 35504422
pii: S1050-1738(22)00066-4
doi: 10.1016/j.tcm.2022.04.007
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

442-455

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Jian Liang Tan (JL)

Division of Cardiovascular Disease, Cooper University Health Care/Cooper Medical School of Rowan University, Camden, New Jersey. Electronic address: tan-jianliang@cooperhealth.edu.

Bryan E-Xin Tan (BE)

Department of Internal Medicine, Rochester General Hospital, Rochester, NY.

Jim W Cheung (JW)

Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, New York.

Matthew Ortman (M)

Division of Cardiovascular Disease, Cooper University Health Care/Cooper Medical School of Rowan University, Camden, New Jersey.

Justin Z Lee (JZ)

Department of Cardiology, Mayo Clinic Arizona, Phoenix, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH